Assessing the performance of Gail's BCRT
using this study's objective risk assessment as gold standard showed that BCRT
performed weakly as a screening tool with a sensitivity of 5.
drives vital research into primary bone cancer to improve the quality of life for patients, to discover better treatments and make this a curable disease.
In conjunction, BCRT
will collaborate for Pluristem's Phase I/II clinical trial in Germany on the regeneration of injured gluteal muscle, as well as on immunological research and the development of new product candidates, through 2017.
Even the NZ Cancer Society is against BCRT
and is hoping to advise cancer groups to drop their association with liquor companies.
Over the next five years of the agreement through 2017, BCRT
and Pluristem will work together on Pluristcm's Phase 1/2 clinical trial in Germany on the regeneration of injured gluteal muscle, as well as on immunological research and the development of new product candidates.
Pluristem and BCRT will collaborate on a variety of indications utilizing mesenchymal stem cells (MSCs) derived from the placenta that have been expanded in the Company's proprietary PluriX[TM] 3-D bioreactor.
Professor Hans Dieter Volk, MD, Director/ Chairman of BCRT at Charite commented, "The collaboration of BCRT, working with Pluristem and their proprietary PLX cells offers several exciting prospects.
The BCRT is a cooperative research institution of the Charite University Hospital in Berlin and Germany's largest research association, the Helmholtz Association.